摘要
背景:阿尔茨海默病(AD)是一种常见的蛋白错误折叠进行性神经退行性疾病,是痴呆的最常见形式之一。淀粉样蛋白前体蛋白(APP)衍生的淀粉样蛋白(Aβ)蛋白积累到神经元间隙中,并在疾病进展及其病理中起关键作用。聚集的Aβ通过诱导神经元细胞凋亡和氧化损伤发挥其神经毒性作用。 目的:我们研究了合成的前药肽(PDp)对人神经母细胞瘤SH-SY5Y细胞中Aβ1-40诱导的细胞毒性的影响,代表了对抗人AD中最有效的策略之一。 方法:用Aβ1-40处理细胞,在AD实验模型中诱导细胞毒作用,筛选PDp的抑制作用。通过Western印迹评估细胞活力,活性氧(ROS)产生,细胞内游离Ca 2+水平和关键凋亡蛋白表达的测定。 结果:我们的研究结果表明,Aβ1-40诱导24h导致细胞活力降低,Ca2 +稳态失衡,神经元凋亡增加。 PDp治疗可有效改善Aβ1-40诱导的神经毒性,并通过Bcl-2,Bax,Caspase-3活性和细胞色素c等途径减弱ROS介导的细胞凋亡信号传导。 结论:这些研究结果表明,PDp具有潜在的作用,作为一个神经保护和治疗剂对抗人类AD。
关键词: 阿尔茨海默病,淀粉状蛋白-β,凋亡,前药肽,活性氧,SH-SY5Y细胞。
Current Alzheimer Research
Title:A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells
Volume: 14 Issue: 12
关键词: 阿尔茨海默病,淀粉状蛋白-β,凋亡,前药肽,活性氧,SH-SY5Y细胞。
摘要: Background: Alzheimer's disease (AD), a common protein misfolding progressive neurodegenerative disorder, is one of the most common forms of dementia. Amyloid precursor protein (APP) derived amyloid-β (Aβ) protein accumulate into interneuronal spaces and plays a crucial role in the disease progression and its pathology. The aggregated Aβ exerts its neurotoxic effects by inducing apoptosis and oxidative damage in neuronal cells.
Objectives: We have investigated the effects of a synthesized Pro-Drug peptide (PDp) on Aβ1-40 induced cytotoxicity in human neuroblastoma SH-SY5Y cells, represents one of the most effective strategies in combating human AD.
Methods: Cells were treated with Aβ1-40 to induce cytotoxicity in the experimental model of AD to screen the inhibitory effect of PDp. Assays for cell viability, reactive oxygen species (ROS) generation, levels of intracellular free Ca2+ and expression of key apoptotic proteins were assessed by Western Blotting.
Results: Our results showed that Aβ1-40 induces for 24h caused reduce cell viability, imbalance in Ca2+ homeostasis and increase in neuronal apoptosis in vitro. Treatment with PDp could effectively ameliorated Aβ1-40 induced neurotoxicity and attenuates ROS generation that mediates apoptotic signaling through Bcl-2, Bax, Caspase-3 activity and cytochrome c in the cells.
Conclusion: These findings suggested that PDp has potential role as a neuroprotective and therapeutic agent for combating human AD.
Export Options
About this article
Cite this article as:
A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells, Current Alzheimer Research 2017; 14 (12) . https://dx.doi.org/10.2174/1567205014666170713153414
DOI https://dx.doi.org/10.2174/1567205014666170713153414 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Infectious Etiology of Alzheimer’s Disease
Current Neuropharmacology High-Throughput Screening Technologies for Botulinum Neurotoxins
Current Topics in Medicinal Chemistry Molecularly Guided Therapy of Neuroblastoma: A Review of Different Approaches
Current Pharmaceutical Design Synthetic Approaches to Various Class of Topoisomerase II Inhibitors
Mini-Reviews in Organic Chemistry Peptides for Tumour Therapy and Diagnosis: Current Status and Future Directions
Current Medicinal Chemistry Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Current Neuropharmacology Small Heat Shock Proteins (sHSPs) As Potential Drug Targets
Current Pharmaceutical Biotechnology Dimethyl-Carbamic Acid 2,3-Bis-Dimethylcarbamoyloxy-6-(4-Ethyl-Piperazine- 1-Carbonyl)-Phenyl Ester: A Novel Multi-Target Therapeutic Approach to Neuroprotection
Medicinal Chemistry Cordycepin in Anticancer Research: Molecular Mechanism of Therapeutic Effects
Current Medicinal Chemistry Zebrafish as a Model System to Screen Radiation Modifiers
Current Genomics The Pathophysiology of Heme in the Brain
Current Alzheimer Research Therapeutic Application of Histone Deacetylase Inhibitors for Stroke
Central Nervous System Agents in Medicinal Chemistry An Association of Virus Infection with Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Hippocampal BDNF Expression in a Tau Transgenic Mouse Model
Current Alzheimer Research Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Current Pharmaceutical Design Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Current Pharmaceutical Design Idiotype Vaccines for Human B-Cell Malignancies
Current Pharmaceutical Design HER2 in the Era of Molecular Medicine: A Review
Current Cancer Therapy Reviews Regulators of G Protein Signaling: Potential Drug Targets for Controlling Cardiovascular and Immune Function
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Targeting the EGFR Pathway for Cancer Therapy
Current Medicinal Chemistry